These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21295198)

  • 21. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidisciplinary intervention to improve medication safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study).
    Krause O; Wiese B; Doyle IM; Kirsch C; Thürmann P; Wilm S; Sparenberg L; Stolz R; Freytag A; Bleidorn J; Junius-Walker U;
    BMC Geriatr; 2019 Jan; 19(1):24. PubMed ID: 30683060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of elderly adults taking warfarin admitted with prolonged international normalized ratio: a community hospital's experience.
    Bergman M; Ori Y; Blumberger N; Brener ZZ; Salman H
    J Am Geriatr Soc; 2012 Sep; 60(9):1713-7. PubMed ID: 22880717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist-led medicine use review in community pharmacy for patients on warfarin.
    Mifsud EM; Wirth F; Camilleri L; Azzopardi LM; Serracino-Inglott A
    Int J Clin Pharm; 2019 Jun; 41(3):741-750. PubMed ID: 31006832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial.
    Dowd MB; Vavra KA; Witt DM; Delate T; Martinez K
    J Thromb Thrombolysis; 2011 May; 31(4):472-7. PubMed ID: 21161329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving Warfarin Management Within the Medical Home: A Health-System Approach.
    Rose AE; Robinson EN; Premo JA; Hauschild LJ; Trapskin PJ; McBride AM
    Am J Med; 2017 Mar; 130(3):365.e7-365.e12. PubMed ID: 27984006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial.
    Anrys P; Strauven G; Boland B; Dalleur O; Declercq A; Degryse JM; De Lepeleire J; Henrard S; Lacour V; Simoens S; Speybroeck N; Vanhaecht K; Spinewine A; Foulon V
    Implement Sci; 2016 Mar; 11():35. PubMed ID: 26968520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
    Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
    Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COSMOS--improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial.
    Husebo BS; Flo E; Aarsland D; Selbaek G; Testad I; Gulla C; Aasmul I; Ballard C
    Implement Sci; 2015 Sep; 10():131. PubMed ID: 26374231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
    Mahaffey KW; Hellkamp AS; Patel MR; Hannan KL; Schwabe K; Nessel CC; Berkowitz SD; Halperin JL; Hankey GJ; Becker RC; Piccini JP; Breithardt G; Hacke W; Singer DE; Califf RM; Fox KA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):470-8. PubMed ID: 23759472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.
    Reardon G; Pandya N; Nutescu EA; Lamori J; Damaraju CV; Schein J; Bookhart BK
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):361-72. PubMed ID: 23217529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Anderson JL; Li J; Rodriguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple B; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2019 Sep; 322(9):834-842. PubMed ID: 31479138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.
    Froggatt K; Best A; Bunn F; Burnside G; Coast J; Dunleavy L; Goodman C; Hardwick B; Jackson C; Kinley J; Davidson Lund A; Lynch J; Mitchell P; Myring G; Patel S; Algorta GP; Preston N; Scott D; Silvera K; Walshe C
    Health Technol Assess; 2020 Jan; 24(6):1-140. PubMed ID: 31971506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents.
    Alcusky M; Tjia J; McManus DD; Hume AL; Fisher M; Lapane KL
    J Gen Intern Med; 2020 Aug; 35(8):2329-2337. PubMed ID: 32291717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and preventability of adverse drug events in nursing homes.
    Gurwitz JH; Field TS; Avorn J; McCormick D; Jain S; Eckler M; Benser M; Edmondson AC; Bates DW
    Am J Med; 2000 Aug; 109(2):87-94. PubMed ID: 10967148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.